Sunday, March 24, 2013

PA Board Of Pharmacy Newsletter Addresses Compounding of Hydroxyprogesterone Caproate Versus Dispensing the Commercial Product, Makena®

This article is written by  Gayle Cotchen, PharmD, Lead Pharmacist, Magee-Womens Hospital of the University of Pittsburgh Medical Center (UPMC),  a graduate of Duquesne University’s School of Pharmacy, and the current acute care institutional member of the State Board of Pharmacy.  To read the newsletter, click here

No comments: